NanoViricides Inc. (NNVC)

[changes_iv]

Indeed I do buy Nanotoday's point.

I don't believe announcing that tox testing has begun will have any material impact on the SP. Announcing results, yes. (now if they have been conducting tox then they could announce results by year's end...but that's all the way full thinking) ~ Nanotoday at investorshub.com

Aug 19, 2013 ---- Nanoviricide, Inc. has also started sub-kg scale production of the injectable FluCide™ anti-influenza drug candidate at its current facility. Safety and toxicology studies of the injectable and oral FluCide drugs are estimated to require very large quantities of the drugs, because of strong safety data evidenced from the in vivo (animal) efficacy studies to date. The Company will be able to initiate GLP Safety/Toxicology studies (“Tox Package”) studies of the injectable FluCide drug when the requisite large amount of drug substance is produced.

Therefore, BASi Toxicology and Safety studies may have seamlessly started once the requisite large amount of drug substance was produced and shipped.

Some of the known catalysts and projected Milestones are:

-Approval for DengueCide® orphan status ~ 3Q 2013
-Well over 100 countries to approve "first in class" patent applications ~ 4Q 2013

-cGMP/R&D Center Shelton CT integration completes ~ 4Q 2013
-Equipment moved into new cGMP plant ~ 4Q 2013
-Commision new cGMP plant (3 identical test batches)~ 1H 2014
-Receive initial results toxicology studies FluCide ~ 4Q 2013
-Prepare IND for submission to regulatory authorities ~ 4Q 2013

The known catalysts and projected milestones are mentioned in the video:

http://youtu.be/lHs2-Js-mQ8

There is no mention in the NanoViricides, Inc. video of a catalyst by announcing the start of "tox studies." The importance is placed in the initial, likely successful results of FluCide "tox studies".

I therefore think we are now waiting for the up-list to the "big board" NYSE MKT LLC and then we are off to the races!

best to all!